CoChat

Statistical approaches for conducting network meta‐analysis in drug development

Jones, Byron, Roger, James, Lane, Peter W., Lawton, Andy, Fletcher, Chrissie, Cappelleri, Joseph C., Tate, Helen, Moneuse, Patrick, on behalf of PSI Health Technology Special Interest Group, Evidence Synthesis sub‐team · 2011 · Pharmaceutical Statistics
Cited by 54

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

We introduce health technology assessment and evidence synthesis briefly, and then concentrate on the statistical approaches used for conducting network meta‐analysis (NMA) in the development and approval of new health technologies. NMA is an extension of standard meta‐analysis where indirect as well as direct information is combined and can be seen as similar to the analysis of incomplete‐block designs. We illustrate it with an example involving three treatments, using fixed‐effects and random‐effects models, and using frequentist and Bayesian approaches. As most statisticians in the pharmaceutical industry are familiar with SAS® software for analyzing clinical trials, we provide example code for each of the methods we illustrate. One issue that has been overlooked in the literature is the choice of constraints applied to random effects, and we show how this affects the estimates and standard errors and propose a symmetric set of constraints that is equivalent to most current practice. Finally, we discuss the role of statisticians in planning and carrying out NMAs and the strategy for dealing with important issues such as heterogeneity. Copyright © 2011 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pst.533

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 54

Metadata

Authors
Jones, B., Roger, J., Lane, P. W., Lawton, A., Fletcher, C., Cappelleri, J. C., Tate, H., Moneuse, P., & on behalf of PSI Health Technology Special Interest Group, E. S. S.
Venue
Pharmaceutical Statistics
Publisher
Wiley
Published
2011-11
Volume
10
Issue
6
Pages
523-531
ISSN
  • 1539-1604 (ISSN-L)
  • 1539-1612
OpenAlex
W2122778917
Cited by
54
References
7
FWCI
6.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statistical approaches for conducting network meta‐analysis in drug development. https://app.cochat.ai/papers/10.1002/pst.533
The paper
Jones, B., Roger, J., Lane, P. W., Lawton, A., Fletcher, C., Cappelleri, J. C., Tate, H., Moneuse, P., & on behalf of PSI Health Technology Special Interest Group, E. S. S. (2011). Statistical approaches for conducting network meta‐analysis in drug development. Pharmaceutical Statistics. https://doi.org/10.1002/pst.533

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.